title: [Life threatening drug-induced hyperkaliemia--case report].
abstract: Patients with congestive heart failure are at increased risk of hyperkalemia due to coexisting morbidities and usage of multiple medications that impair potassium excretion--such as angiotensin-converting enzyme inhibitors or spironolactone. Because of the risk of this disturbance, knowledge of causation and prevention is mandatory. We described 3 patients with life threatening hyperkalemia (>8.5 mEq/t) caused by drugs. We showed the symptoms of increased potassium level, the list of medications and comorbidities predisposing to hyperkalemia. After a few days of medical treatment and dialysis, potasium level normalized in all of our patients.
authors.affiliation: Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych Akademii Medycznej w Gdańsku. jkonopa@amg.gda.pl
authors.forename: Joanna
authors.initials: J
authors.lastname: Konopa
authors.forename: Barbara
authors.initials: B
authors.lastname: Bullo
authors.forename: Bolesław
authors.initials: B
authors.lastname: Rutkowski
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000188:drug therapy / Q000628:therapy; D008297:Male; D006435:Renal Dialysis; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors